Study title: A multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the safety and efficacy of lamotrigine in subjects with neuropathic pain and inadequate pain relief with gabapentin, tricyclic antidepressants or non-narcotic analgesics.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Anesthesia and Analgesia | |||||
Brands: | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: LAMOTRIGINE | |||||
ATC code: | |||||
Document link: Lamotrigine-Lamotrigine-NPP30010-ICHE3.pdf | |||||
Document date: 2011-10-18 | |||||
Study number: NPP30010 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |